Search

The article discusses the study conducted by Li and colleagues on the prevalence of dementia among the indigenous and the non-indigenous people of the Northern Territory. Noted finding of the study include the higher rate of prevalence among the indigenous population than the non-indigenous people. Mentioned are diagnostic categories of dementia as well as contributing health risk factors for the disease.

Abstract: Neoseiulus baraki Athias-Henriot (Acari: Phytoseiidae) is an important predatory mite of the coconut mite, Aceria guerreronis Keifer (Acari: Eriophyidae) and attempts are now being made to evaluate the effectiveness of augmenting N. baraki to control coconut mite in the field. These studies require a steady supply of N. baraki in large numbers. One major constraint of the existing method to mass rear N. baraki on Tyrophagus putrescentiae Shrank (Acari: Acaridae) in a closed arena without a water barrier was frequent contamination of cultures by other mites. This paper describes the development of an efficient method to mass rear N. baraki in the laboratory with less monitoring and relatively minimal contaminants. Three box-type arenas and a tray-type arena were tested to mass rear T. putrescentiae. Mites were successfully developed on two box-type arenas and the tray-type arena, but the production (2197 mites per tray in 4 weeks) of T. putrescentiae was significantly higher on the tray-type arena. A 110-fold increase of T. putrescentiae was achieved in tray-type arenas in 4 weeks. None of the box-type arenas could be maintained more than 5 weeks without acarine and fungal contaminations. N. baraki could be successfully reared on the tray-type arena at least for 6 weeks. More than 4800 mites per tray, a 240-fold increase was achieved in 5 weeks when T. putrescentiae was added at 3-week intervals. Advantages and disadvantages of the new method are described. [Copyright &y& Elsevier]

Objectives: To describe the epidemiology of mumps and examine potential factors underlying the recent increase in the incidence of mumps in Australia.Design, Setting and Participants: Analytical descriptive study, for all Australian states and territories, of mumps notifications (1994-2007); hospitalisations for mumps (1994-2005); and mumps seroprevalence in a nationally representative sample of 2787 subjects (1997).Main Outcome Measures: Incidence of notifications and hospitalisations for mumps; seropositivity by birth cohort.Results: Notified mumps cases increased from 60 in 2002 to 231 in 2005 and 512 in 2007. Between 1994 and 2005, there were 605 hospitalisations for mumps. Mumps seropositivity in all states and territories in 1997 was high (range, 87.1%-94.3%). The predominant age group affected by mumps shifted to adults over time: between 2005 and 2007, 41% of cases occurred among people aged 20-29 years. Cases were concentrated among the birth cohort of 1978 to 1982, who had higher rates of notifications and hospitalisations for mumps and a lower seropositivity rate (92% [95% CI, 89%-94%]) than other birth cohorts.Conclusions: The birth cohort of 1978 to 1982 was too old to reliably receive a second dose of measles-mumps-rubella (MMR) vaccine in the 1998 Australian Measles Control Campaign and too young to have had mumps infection. Renewed efforts to maximise two-dose MMR coverage are important for prevention of mumps and measles in young adults. [ABSTRACT FROM AUTHOR]

Lymphatic filariasis (LF) is a major public health problem globally and in the Pacific Region. The Global Programme to Eliminate LF has made great progress but LF is persistent and resurgent in some Pacific countries and territories. Samoa remains endemic for LF despite elimination efforts through multiple two-drug mass drug administrations (MDA) since 1965, including renewed elimination efforts started in 1999 under the Pacific Programme for Elimination of LF (PacELF). Despite eight rounds of national and two rounds of subnational MDA under PacELF, Samoa failed transmission assessment surveys (TAS) in all three evaluation units in 2017. In 2018, Samoa was the first to distribute countrywide triple-drug MDA using ivermectin, diethylcarbamazine (DEC), and albendazole. This paper provides a review of MDAs and historical survey results from 1998 to 2017 in Samoa and highlights lessons learnt from LF elimination efforts, including challenges and potential ways to overcome them to successfully achieve elimination., (Copyright © 2021 Elsevier Ltd. All rights reserved.)

Neglected tropical diseases (NTDs) cause serious health, social and economic burdens in the countries of the World Health Organization Western Pacific Region. Among the NTDs, helminth infections are particularly prominent with regard to the number of infected individuals and health impact. Co-endemicity is common among impoverished and marginalized populations. To achieve effective and sustainable control of helminth NTDs, a deeper understanding of the social-ecological systems governing their endemicity and strategies beyond preventive chemotherapy are required to tackle the multiple causes of infection and re-infection. We discuss the feasibility of implementing multi-disease, multi-sectoral intervention packages for helminth NTDs in the Western Pacific Region. After reviewing the main determinants for helminth NTD endemicity and current control strategies, key control activities that involve or concern other programmes within and beyond the health sector are discussed. A considerable number of activities that have an impact on more than one helminth NTD are identified in a variety of sectors, suggesting an untapped potential for synergies. We also highlight the challenges of multi-sectoral collaboration, particularly of involving non-health sectors. We conclude that multi-sectoral collaboration for helminth NTD control is feasible if the target diseases and sectors are carefully selected. To do so, an incentive analysis covering key stakeholders in the sectors is crucial, and the disease-control strategies need to be well understood. The benefits of multi-disease, multi-sectoral approaches could go beyond immediate health impacts by contributing to sustainable development, raising educational attainment, increasing productivity and reducing health inequities., (Copyright © 2013 Elsevier B.V. All rights reserved.)

Objective: To estimate the prevalence and incidence of dementia in Northern Territory Indigenous and non-Indigenous populations., Design, Setting and Participants: Four data sources were used to identify clients with a diagnosis of dementia, from 1 January 2008 to 31 December 2011. The data sources included hospital admissions, aged care services, primary care and death registration. A capture-recapture method was used to estimate prevalence and incidence, including both diagnosed and unknown cases., Main Outcome Measures: Prevalence and incidence of dementia among the NT Indigenous and non-Indigenous populations., Results: In 2011, the estimated prevalence in the NT Indigenous population aged 45 years and over was 3.7 per 100, and 1.1 per 100 in the corresponding NT non-Indigenous population. The age-adjusted prevalence for the NT Indigenous population was 6.5 per 100, compared with the NT non-Indigenous prevalence of 2.6 per 100, which was similar to the national rate. The prevalence rate ratios of NT Indigenous to NT non-Indigenous men and women, respectively, were: 6.5 and 5.5 for the 45-64-years age group, 4.0 and 4.1 for those aged 65-74 years and 2.1 and 1.9 for those aged 75 years and over. The age-adjusted incidence among the NT Indigenous population aged 45 years and over (27.3 per 1000 person-years) was higher than that among the NT non-Indigenous population (10.7 per 1000 person-years)., Conclusion: The NT Indigenous population has a much higher prevalence and incidence of dementia and younger onset of disease compared with their non-Indigenous counterparts. The results highlight the urgent need for interventions to moderate the emerging impact of dementia in the Australian Indigenous population.